CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl) -6H-pyrrolo[3,2,1 ij]quinolin-6-one]-induced hypothermia

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 3, 2002, Pages 963-968

  Rawls, Scott M ^a   Cabassa, Jose ^a   Geller, Ellen B ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; RIMONABANT; ANALGESIC AGENT; CANNABINOID; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR CB2, RAT; DRUG RECEPTOR; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPOTHERMIA; NONHUMAN; PREOPTIC NUCLEUS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THERMOREGULATION; ANIMAL; BODY TEMPERATURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREOPTIC AREA; SPRAGUE DAWLEY RAT;

ANALGESICS; ANIMALS; BODY TEMPERATURE; CANNABINOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHERMIA; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHOLINES; NAPHTHALENES; PREOPTIC AREA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0036015112     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.3.963     Document Type: Article

References (40)

1. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
2. Hypothalamic mechanisms in thermoregulation
3. Control of pain initiation by endogenous cannabinoids
4. Behavioral effects of cannabinoid agents in animals
5. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity
6. Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol
7. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice
8. Determination and characterization of a cannabinoid receptor in rat brain
9. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
10. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212
11. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation
12. Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetahyrocannabinol
13. The role of central and peripheral cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain
14. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
15. Pharmacology of cannabinoid receptors
16. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
17. 1 receptor knockout mice
18. Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 C132 receptors
19. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
20. Modulation of delta9- tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat
21. Cannabinoid receptor-mediated inhibition of the rat tail flick reflex after microinjection into the rostral ventromedial medulla
22. Aversive effects of the synthetic cannabinoid CP 55,940 in rats
23. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study
24. Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats
25. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens
26. Cross-tolerance between delta 9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide
27. Immunohistochemical localization of the neural cannabinoid receptor in rat brain
28. SR141617A, a potent and selective antagonist of the brain cannabinoid receptor
29. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
30. Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation
31. Hypothermic effects of intraventricular and intravenous administration of cannabinoids in intact and brainstem transected cats
32. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
33. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
34. A role of nitric oxide in WIN 55,212-2 tolerance in mice
35. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
36. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A
37. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats
38. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain
39. Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice